GLOW
BPC-157 · GHK-Cu · TB-500 · Lyophilised Blend
Where cellular science
meets luminous biology.
GLOW represents the convergence of three of the most extensively studied regenerative peptides in modern biochemistry. At its foundation, BPC-157 — a 15-amino-acid sequence derived from human gastric juice — has been explored across hundreds of preclinical studies for its apparent capacity to accelerate tissue repair, stimulate angiogenesis, and modulate nitric oxide signalling pathways. Its pleiotropic profile makes it a cornerstone compound in regenerative research.
GHK-Cu (copper tripeptide-1) is a naturally occurring plasma tripeptide with a remarkable affinity for copper ions. Research has consistently associated GHK-Cu with the upregulation of collagen, elastin, and glycosaminoglycan synthesis in fibroblast models, alongside significant anti-inflammatory and antioxidant activity. Investigations in dermal biology suggest it may influence the expression of over 4,000 human genes — including many linked to wound closure, anti-aging mechanisms, and structural protein restoration. TB-500, a synthetic analogue of Thymosin Beta-4, completes the triad — studied for its role in actin regulation, keratinocyte migration, and vascular network formation that underpins effective tissue remodelling.
BPC-157 · 10mg
Pentadecapeptide studied extensively for mucosal integrity, tendon healing, and systemic cytoprotective effects across multiple organ systems.
GHK-Cu · 50mg
Copper tripeptide with established fibroblast-stimulating activity. Investigated for collagen I/III ratio restoration, antioxidant gene induction, and dermal matrix remodelling.
TB-500 · 10mg
Thymosin Beta-4 synthetic fragment. Studied for actin sequestration, keratinocyte migration, and angiogenic activity in wound-healing and skin-regeneration models.
